◆ NeutralNVS

All You Need to Know About Novartis (NVS) Rating Upgrade to Buy

Zacks Investment Research·
All You Need to Know About Novartis (NVS) Rating Upgrade to Buy

Novartis (NVS) has been upgraded to Zacks Rank #2 (Buy) due to upward trends in earnings estimates. The company is expected to earn $9.02 per share for fiscal year 2026, with analysts raising consensus estimates by 2% over the past three months. The upgrade positions Novartis in the top 20% of Zacks-covered stocks, suggesting potential for near-term stock price appreciation.

Read Full Article at Zacks Investment Research →
← Back to Financial Intelligence